{"recordsFiltered":50813,"recordsTotal":50813,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=status&start=42600","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=status&start=42000","results":[{"registry_id":"NCT04159103","publication_url":"https://clinicaltrials.gov/study/NCT04159103","title":"A Global, Phase 1/2, Open-Label, Dose Optimization Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants With Propionic Acidemia","has_exemption":false,"start_date":"2021-04-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04957355","publication_url":"https://clinicaltrials.gov/study/NCT04957355","title":"Effect of Neuromuscular Electrical Stimulation (NMES) on Reactive Balance, Gait and Fall-risk in Individuals With Stroke","has_exemption":false,"start_date":"2021-05-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04240561","publication_url":"https://clinicaltrials.gov/study/NCT04240561","title":"Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia","has_exemption":false,"start_date":"2021-07-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04087629","publication_url":"https://clinicaltrials.gov/study/NCT04087629","title":"Post-marketing Surveillance of StrataCTX® Flexible Wound Dressing for Use as a Steroid Sparing Agent","has_exemption":false,"start_date":"2021-07-07","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04171622","publication_url":"https://clinicaltrials.gov/study/NCT04171622","title":"Lenvatinib in Combination With Pembrolizumab for Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer","has_exemption":false,"start_date":"2021-11-04","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04061421","publication_url":"https://clinicaltrials.gov/study/NCT04061421","title":"The ABNL-MARRO 001 Study: A Phase 1/2 Study of Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes.","has_exemption":false,"start_date":"2021-11-24","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Michael Savona","sponsor_slug":"michael-savona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04758624","publication_url":"https://clinicaltrials.gov/study/NCT04758624","title":"Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor After Successful Deep Brain Stimulation to the Dentato-rubro-thalamic Tract","has_exemption":false,"start_date":"2021-12-04","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05134857","publication_url":"https://clinicaltrials.gov/study/NCT05134857","title":"Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework","has_exemption":false,"start_date":"2022-01-07","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Washington State University","sponsor_slug":"washington-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05081609","publication_url":"https://clinicaltrials.gov/study/NCT05081609","title":"IL Believe: A Phase 1/2, Open-label, Dose Escalation and Dose Expansion Study to Investigate the Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab, TransCon TLR7/8 Agonist, or Other Anticancer Therapies, in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies","has_exemption":false,"start_date":"2022-01-11","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Ascendis Pharma Oncology Division A/S","sponsor_slug":"ascendis-pharma-oncology-division-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05150691","publication_url":"https://clinicaltrials.gov/study/NCT05150691","title":"A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1303/BNT323 in Patients With Advanced/Metastatic Solid Tumors","has_exemption":false,"start_date":"2022-01-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"DualityBio Inc.","sponsor_slug":"dualitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04917809","publication_url":"https://clinicaltrials.gov/study/NCT04917809","title":"A Phase 2 \"Window of Opportunity\" Trial of Targeted Therapy With Erdafitinib in Patients With Recurrent FGFR3-Altered Non-Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2022-02-17","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04883411","publication_url":"https://clinicaltrials.gov/study/NCT04883411","title":"First-in-human Prospective Study to Assess the Safety and Efficacy of the CEM-Cage and CEM-Plate","has_exemption":false,"start_date":"2022-03-07","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"ReVivo Medical, Corp.","sponsor_slug":"revivo-medical-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04421365","publication_url":"https://clinicaltrials.gov/study/NCT04421365","title":"Adaptive Closed-loop Brain-computer Interface Therapeutic Intervention in Laryngeal Dystonia","has_exemption":false,"start_date":"2022-04-18","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Kristina Simonyan","sponsor_slug":"kristina-simonyan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727942","publication_url":"https://clinicaltrials.gov/study/NCT06727942","title":"Toward Healthy Living: Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes","has_exemption":false,"start_date":"2022-05-10","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Arlington","sponsor_slug":"the-university-of-texas-at-arlington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05973461","publication_url":"https://clinicaltrials.gov/study/NCT05973461","title":"Effects of Exercise With Virtual Reality on Females and Males With or Without Depression","has_exemption":false,"start_date":"2022-05-17","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Arlington","sponsor_slug":"the-university-of-texas-at-arlington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05262907","publication_url":"https://clinicaltrials.gov/study/NCT05262907","title":"Assessment of Ventricular Volumes and Function in Single Ventricle Patients Using Ventripoint 3D Echocardiography","has_exemption":false,"start_date":"2022-07-08","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04792502","publication_url":"https://clinicaltrials.gov/study/NCT04792502","title":"BrUOG 401: A Phase 2 Study of Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma","has_exemption":false,"start_date":"2022-07-14","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05450965","publication_url":"https://clinicaltrials.gov/study/NCT05450965","title":"A Phase 2 Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer","has_exemption":false,"start_date":"2022-07-19","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05389787","publication_url":"https://clinicaltrials.gov/study/NCT05389787","title":"Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study","has_exemption":false,"start_date":"2022-08-18","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05515575","publication_url":"https://clinicaltrials.gov/study/NCT05515575","title":"Phase II Study of Niraparib in Soft Tissue Sarcoma Patients With Altered DNA Damage Repair","has_exemption":false,"start_date":"2022-08-23","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06118567","publication_url":"https://clinicaltrials.gov/study/NCT06118567","title":"Nitrous Oxide and Cortico-Limbic Function in Aggression","has_exemption":false,"start_date":"2022-09-06","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05563805","publication_url":"https://clinicaltrials.gov/study/NCT05563805","title":"Exploring Virtual Reality Adventure Training Exergaming (V-RATE) on Veterans' Health Outcomes","has_exemption":false,"start_date":"2022-09-07","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Arlington","sponsor_slug":"the-university-of-texas-at-arlington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444361","publication_url":"https://clinicaltrials.gov/study/NCT05444361","title":"Eliminating Post-Mastectomy Pain and Opioids With Percutaneous Cryoneurolysis: A Single-Administration, Non-Opioid, Non-Addictive, Multiple-Month Analgesic","has_exemption":false,"start_date":"2022-09-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05544721","publication_url":"https://clinicaltrials.gov/study/NCT05544721","title":"Pre-Operative and Post-Operative Paravertebral Block on Patients With Thoracic Outlet Syndrome.","has_exemption":false,"start_date":"2022-10-05","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05491915","publication_url":"https://clinicaltrials.gov/study/NCT05491915","title":"The MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Case Series Study: Treatment of Head Pain With the SPRINT® Peripheral Nerve Stimulation (PNS) System","has_exemption":false,"start_date":"2022-10-24","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"SPR Therapeutics, Inc.","sponsor_slug":"spr-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05607420","publication_url":"https://clinicaltrials.gov/study/NCT05607420","title":"Open-label Dose-finding and Dose-expansion Study to Evaluate the Safety, Expansion, Persistence, and Clinical Activity of UCART20x22 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (B-NHL)","has_exemption":false,"start_date":"2022-11-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Cellectis S.A.","sponsor_slug":"cellectis-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05641935","publication_url":"https://clinicaltrials.gov/study/NCT05641935","title":"Multi-Modality Detection of RCC Recurrence Post Ablation","has_exemption":false,"start_date":"2022-11-03","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"john eisenbrey","sponsor_slug":"john-eisenbrey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06211634","publication_url":"https://clinicaltrials.gov/study/NCT06211634","title":"A Phase 1/2, First-in-Human, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants With Glanzmann Thrombasthenia","has_exemption":false,"start_date":"2022-12-13","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Hemab ApS","sponsor_slug":"hemab-aps","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05506943","publication_url":"https://clinicaltrials.gov/study/NCT05506943","title":"A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination With Paclitaxel Versus Paclitaxel Alone in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers Who Have Received One Prior Systemic Chemotherapy Regimen","has_exemption":false,"start_date":"2023-01-09","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Compass Therapeutics","sponsor_slug":"compass-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672927","publication_url":"https://clinicaltrials.gov/study/NCT05672927","title":"Comparison of the Immune Response After Administration of 2 vs. 3 Doses of the FDA-approved 9-Valent HPV Vaccine Among Women 27-45 Years of Age","has_exemption":false,"start_date":"2023-01-18","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05702944","publication_url":"https://clinicaltrials.gov/study/NCT05702944","title":"A Pilot Study for Randomized Controlled Trial on the Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma","has_exemption":false,"start_date":"2023-01-18","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Seoul National University Hospital","sponsor_slug":"seoul-national-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05489588","publication_url":"https://clinicaltrials.gov/study/NCT05489588","title":"Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Iliofemoral Venous Obstruction","has_exemption":false,"start_date":"2023-03-02","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"W.L.Gore & Associates","sponsor_slug":"wlgore-associates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05695027","publication_url":"https://clinicaltrials.gov/study/NCT05695027","title":"Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study","has_exemption":false,"start_date":"2023-03-14","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05389930","publication_url":"https://clinicaltrials.gov/study/NCT05389930","title":"Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods","has_exemption":false,"start_date":"2023-03-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05462496","publication_url":"https://clinicaltrials.gov/study/NCT05462496","title":"Pilot Study of Gut Microbiome Modulation to Enable Efficacy of Neoadjuvant Checkpoint-based Immunotherapy Following Chemotherapy in Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2023-03-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05550194","publication_url":"https://clinicaltrials.gov/study/NCT05550194","title":"VZV in the Enteric Nervous System: Pathogenesis and Consequences","has_exemption":false,"start_date":"2023-03-27","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05020860","publication_url":"https://clinicaltrials.gov/study/NCT05020860","title":"A Phase II Trial to Correlate Early Clinical Response to Pathologic Outcome With Neoadjuvant Systemic Therapy in Patients With Early Stage Breast Cancer","has_exemption":false,"start_date":"2023-04-18","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Baylor Breast Care Center","sponsor_slug":"baylor-breast-care-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05661903","publication_url":"https://clinicaltrials.gov/study/NCT05661903","title":"From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects","has_exemption":false,"start_date":"2023-06-08","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05600894","publication_url":"https://clinicaltrials.gov/study/NCT05600894","title":"Venetoclax In Combination With ASTX727, an All-ORal TherapY for Chronic Myelomonocytic Leukemia and Other MDS/MPN With Excess Blasts (VICTORY-MDS/MPN): a Randomized, Phase 2 Trial","has_exemption":false,"start_date":"2023-06-27","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05671510","publication_url":"https://clinicaltrials.gov/study/NCT05671510","title":"Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers That Progressed on PD-1/PD-L1 Inhibitors","has_exemption":false,"start_date":"2023-06-28","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"OncoC4, Inc.","sponsor_slug":"oncoc4-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05754073","publication_url":"https://clinicaltrials.gov/study/NCT05754073","title":"A Randomized, Double-blind, Placebo-controlled Study of Intranasal Oxytocin for Bone Health in Children With Autism Spectrum Disorder","has_exemption":false,"start_date":"2023-08-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Elizabeth Austen Lawson","sponsor_slug":"elizabeth-austen-lawson","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06223633","publication_url":"https://clinicaltrials.gov/study/NCT06223633","title":"PK(Pharmacokinetic) Papyrus Covered Coronary Stent System","has_exemption":false,"start_date":"2023-08-10","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Methodist Health System","sponsor_slug":"methodist-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05836259","publication_url":"https://clinicaltrials.gov/study/NCT05836259","title":"First-in-Human, Open-Label, Safety, Tolerability, Dose-Finding, Pharmacodynamic and Cardiac Transgene Expression Study of TN-201, a Recombinant Adeno-associated Virus Serotype 9 (AAV9) Containing Myosin Binding Protein C Transgene, in Adults With MYBPC3 Mutation-associated Hypertrophic Cardiomyopathy (HCM)","has_exemption":false,"start_date":"2023-08-10","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Tenaya Therapeutics","sponsor_slug":"tenaya-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04695600","publication_url":"https://clinicaltrials.gov/study/NCT04695600","title":"Efficacy and Safety of Onabotulinum Toxin A (Botox) Injections in the Upper Esophageal Sphincter for the Treatment of Pharyngo-esophageal Dysphagia Due to Cricopharyngeal Dysfunction- A Randomized Double Blinded Placebo Controlled Trial","has_exemption":false,"start_date":"2023-08-11","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"All India Institute of Medical Sciences","sponsor_slug":"all-india-institute-of-medical-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05842057","publication_url":"https://clinicaltrials.gov/study/NCT05842057","title":"Phase 2 Randomized Trial: Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy (HAMMER)","has_exemption":false,"start_date":"2023-08-24","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05693766","publication_url":"https://clinicaltrials.gov/study/NCT05693766","title":"Integrating Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort (INSIGHT)","has_exemption":false,"start_date":"2023-09-28","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Sonya Reid","sponsor_slug":"sonya-reid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06117332","publication_url":"https://clinicaltrials.gov/study/NCT06117332","title":"AI-Powered Artificial Vision for Visual Prostheses","has_exemption":false,"start_date":"2023-10-02","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Santa Barbara","sponsor_slug":"university-of-california-santa-barbara","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05918861","publication_url":"https://clinicaltrials.gov/study/NCT05918861","title":"Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS)","has_exemption":false,"start_date":"2023-10-03","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"DalCor Pharmaceuticals","sponsor_slug":"dalcor-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06094205","publication_url":"https://clinicaltrials.gov/study/NCT06094205","title":"Understanding and Restoring Speech Production Using an Intracortical Brain-computer Interface","has_exemption":false,"start_date":"2023-10-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Leigh R. Hochberg, MD, PhD.","sponsor_slug":"leigh-r-hochberg-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06084936","publication_url":"https://clinicaltrials.gov/study/NCT06084936","title":"A Phase III, Open-Label, Multicenter Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients With Relapsed/Refractory Mantle Cell Lymphoma","has_exemption":false,"start_date":"2023-10-22","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05972135","publication_url":"https://clinicaltrials.gov/study/NCT05972135","title":"Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma","has_exemption":false,"start_date":"2023-10-23","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"SCRI Development Innovations, LLC","sponsor_slug":"scri-development-innovations-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05986084","publication_url":"https://clinicaltrials.gov/study/NCT05986084","title":"Linking HIV Prevention and Postpartum Care: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a High-Risk Breastfeeding Population in Botswana","has_exemption":false,"start_date":"2023-11-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06213012","publication_url":"https://clinicaltrials.gov/study/NCT06213012","title":"Harnessing Neuroplasticity of Postural Sensorimotor Networks Using Non-Invasive Spinal Neuromodulation to Maximize Functional Recovery After Spinal Cord Injury","has_exemption":false,"start_date":"2023-12-06","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05863351","publication_url":"https://clinicaltrials.gov/study/NCT05863351","title":"Phase III Randomized Trial of Stereotactic Ablative Radiotherapy (SAbR) for Oligometastatic Advanced Renal Carcinoma (SOAR)","has_exemption":false,"start_date":"2023-12-27","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06247085","publication_url":"https://clinicaltrials.gov/study/NCT06247085","title":"A Phase 3, Parallel-Group Treatment, Blinded, Randomized, Placebo-Controlled Study To Assess The Efficacy And Safety Of Pegtibatinase Administered Subcutaneously In Addition To Standard Of Care In Participants With Classical Homocystinuria Due To Cystathionine Beta Synthase Deficiency (HARMONY)","has_exemption":false,"start_date":"2023-12-28","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Travere Therapeutics, Inc.","sponsor_slug":"travere-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06027268","publication_url":"https://clinicaltrials.gov/study/NCT06027268","title":"ToPCourT: A Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (TNBC)","has_exemption":false,"start_date":"2024-01-10","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06064877","publication_url":"https://clinicaltrials.gov/study/NCT06064877","title":"A Multicenter, Randomized, Double Blind, Placebo - Controlled, Phase 3 Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV -Negative Head and Neck Squamous Cell Carcinoma. (FIERCE-HN)","has_exemption":false,"start_date":"2024-01-11","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"AVEO Pharmaceuticals, Inc.","sponsor_slug":"aveo-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07853768","publication_url":"https://clinicaltrials.gov/study/NCT07853768","title":"MSK Injury Assessment Imaging System: Feasibility and Data Acquisition for Algorithm Development and Testing","has_exemption":false,"start_date":"2024-01-29","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Rivanna Medical, Inc.","sponsor_slug":"rivanna-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06105554","publication_url":"https://clinicaltrials.gov/study/NCT06105554","title":"Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2024-01-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06085716","publication_url":"https://clinicaltrials.gov/study/NCT06085716","title":"Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers","has_exemption":false,"start_date":"2024-02-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04597437","publication_url":"https://clinicaltrials.gov/study/NCT04597437","title":"Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE): A Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2024-03-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"George Washington University","sponsor_slug":"george-washington-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06057675","publication_url":"https://clinicaltrials.gov/study/NCT06057675","title":"Subcutaneous Tranexamic Acid in Nasal Mohs Local Flap Reconstruction: Perioperative Bleeding, Edema, and Ecchymosis","has_exemption":false,"start_date":"2024-03-19","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06205121","publication_url":"https://clinicaltrials.gov/study/NCT06205121","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of a 12-week Administration of OATD-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis (the KITE Study)","has_exemption":false,"start_date":"2024-03-21","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Molecure S.A.","sponsor_slug":"molecure-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02998229","publication_url":"https://clinicaltrials.gov/study/NCT02998229","title":"Artisse™ Intrasaccular Device IDE","has_exemption":false,"start_date":"2024-04-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Neurovascular Clinical Affairs","sponsor_slug":"medtronic-neurovascular-clinical-affairs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06373731","publication_url":"https://clinicaltrials.gov/study/NCT06373731","title":"ReNEW: A Phase 3, Double-Masked, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects Who Have Dry Age-Related Macular Degeneration (Dry AMD)","has_exemption":false,"start_date":"2024-05-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Stealth BioTherapeutics Inc.","sponsor_slug":"stealth-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298343","publication_url":"https://clinicaltrials.gov/study/NCT07298343","title":"A Phase II, Double-blind, Randomised, Placebo-controlled Trial to Evaluate the Efficacy and Tolerability of ZED1227 in Celiac Disease Subjects Experiencing Symptoms Despite Gluten-free Diet","has_exemption":false,"start_date":"2024-06-10","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Dr. Falk Pharma GmbH","sponsor_slug":"dr-falk-pharma-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05994053","publication_url":"https://clinicaltrials.gov/study/NCT05994053","title":"Neuromodulation for a Novel OCD Biomarker and Treatment","has_exemption":false,"start_date":"2024-07-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Boston University Charles River Campus","sponsor_slug":"boston-university-charles-river-campus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06352788","publication_url":"https://clinicaltrials.gov/study/NCT06352788","title":"From Opinion to Evidence: Multi-site Evaluation of Custom Dynamic Orthosis Best Practices","has_exemption":false,"start_date":"2024-07-02","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Jason Wilken","sponsor_slug":"jason-wilken","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06455969","publication_url":"https://clinicaltrials.gov/study/NCT06455969","title":"Musculoskeletal Resiliency and Adaptation to Sex Steroid Suppression and Replacement During Multi-Stressor Training","has_exemption":false,"start_date":"2024-07-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Bradley Nindl","sponsor_slug":"bradley-nindl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06100913","publication_url":"https://clinicaltrials.gov/study/NCT06100913","title":"An Open-label Interventional Study to Understand and Quantify the Duration of Humoral Immunological Memory to a Single Dose of Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)","has_exemption":false,"start_date":"2024-08-06","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06423326","publication_url":"https://clinicaltrials.gov/study/NCT06423326","title":"A Single-Arm Phase II Clinical Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2024-08-06","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06549465","publication_url":"https://clinicaltrials.gov/study/NCT06549465","title":"A Phase 2, Open-label Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2024-08-06","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Convergent Therapeutics","sponsor_slug":"convergent-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06293352","publication_url":"https://clinicaltrials.gov/study/NCT06293352","title":"Durable, Real-component Antibiotic Spacers vs All-cement Articulating Spacers for the Treatment of Periprosthetic Knee Infection","has_exemption":false,"start_date":"2024-08-08","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06407232","publication_url":"https://clinicaltrials.gov/study/NCT06407232","title":"An Interventional Study of Letermovir for Secondary Prophylaxis After Treatment of Cytomegalovirus Infection in High Risk (D+/R-) Kidney and Kidney/Pancreas Transplant Recipients","has_exemption":false,"start_date":"2024-08-08","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06373458","publication_url":"https://clinicaltrials.gov/study/NCT06373458","title":"A Single-Center, Two-Arm, Open-Label Phase IIA Clinical Trial to Investigate Efficacy and Safety of Ritlecitinib in Patients With Keloid","has_exemption":false,"start_date":"2024-08-13","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06388226","publication_url":"https://clinicaltrials.gov/study/NCT06388226","title":"Leg Heat Therapy to Improve Functional Performance in Heart Failure With Preserved Ejection Fraction (HFpEF)","has_exemption":false,"start_date":"2024-08-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06563479","publication_url":"https://clinicaltrials.gov/study/NCT06563479","title":"Phase III Randomized and Double-blinded Trial of De-escalated Radiation in FMISO PET-selected Good Risk Versus Standard of Care Radiation in Unselected HPV Positive Oropharyngeal Cancer","has_exemption":false,"start_date":"2024-08-19","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06376526","publication_url":"https://clinicaltrials.gov/study/NCT06376526","title":"Immuno-consolidation for Newly Diagnosed Multiple Myeloma Using Lack of MRD Negativity After Initial cOmbination Therapy to Pursue Deeper Responses With Linvoseltamab ANd Delay Transplant","has_exemption":false,"start_date":"2024-08-21","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Dickran Kazandjian, MD","sponsor_slug":"dickran-kazandjian-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05988385","publication_url":"https://clinicaltrials.gov/study/NCT05988385","title":"The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults (ESSENTIAL) Study","has_exemption":false,"start_date":"2024-08-29","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"California Pacific Medical Center Research Institute","sponsor_slug":"california-pacific-medical-center-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06582771","publication_url":"https://clinicaltrials.gov/study/NCT06582771","title":"A Phase 2 Study of First-line Sotorasib for Patients With Advanced KRAS G12C-mutant Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2024-08-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06116136","publication_url":"https://clinicaltrials.gov/study/NCT06116136","title":"Open Label, Non-randomized, Phase 1b/2 Trial Investigating the Safety, Tolerability, and Antitumor Activity of S095029 (Anti-NKG2A Antibody) as a Part of Combination Therapy in Participants With Locally Advanced and Unresectable or Metastatic MSI-H/dMMR Gastro-esophageal Junction /Gastric Cancer","has_exemption":false,"start_date":"2024-08-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Servier Bio-Innovation LLC","sponsor_slug":"servier-bio-innovation-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06370182","publication_url":"https://clinicaltrials.gov/study/NCT06370182","title":"A Prospective, Randomized, Dual-arm Multi-center Study to Assess the Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter in Combination With a Stent Retriever","has_exemption":false,"start_date":"2024-09-09","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Anaconda Biomed S.L.","sponsor_slug":"anaconda-biomed-sl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06547021","publication_url":"https://clinicaltrials.gov/study/NCT06547021","title":"Investigating the Effect of Different Frequencies of Transcranial Electrical Stimulations Paired With Cognitive Training on the Executive Brain Functions in Dementia Population","has_exemption":false,"start_date":"2024-09-20","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Manitoba","sponsor_slug":"university-of-manitoba","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06488222","publication_url":"https://clinicaltrials.gov/study/NCT06488222","title":"Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer","has_exemption":false,"start_date":"2024-11-05","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06614192","publication_url":"https://clinicaltrials.gov/study/NCT06614192","title":"AndroMETa-CRC-064: An Open-Label, Randomized Global Dose Optimization Study Comparing Two Doses of Telisotuzumab Adizutecan (ABBV-400) Monotherapy in Subjects With Refractory Metastatic Colorectal Cancer Expressing c-Met Protein Level Above a Defined Cutoff","has_exemption":false,"start_date":"2024-11-08","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06676956","publication_url":"https://clinicaltrials.gov/study/NCT06676956","title":"The SEQUENCE Trial: Should Endobronchial Ultrasound QUeue bEfore or eNsuing to robotiC-assisted Bronchoscopy for pEripheral Pulmonary Nodule Biopsy?","has_exemption":false,"start_date":"2024-11-10","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06518564","publication_url":"https://clinicaltrials.gov/study/NCT06518564","title":"A Phase 2 Study of Avelumab in Combination With ATR Inhibitor M1774 in Patients With ARID1A-mutated Recurrent Endometrial Cancer Who Have Received Prior Immunotherapy","has_exemption":false,"start_date":"2024-11-14","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Panagiotis Konstantinopoulos, MD, PhD","sponsor_slug":"panagiotis-konstantinopoulos-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06594705","publication_url":"https://clinicaltrials.gov/study/NCT06594705","title":"Transcatheter Aortic Valve Replacement Using the JenaValve TrilogyTM Heart Valve System for Clinically Significant Aortic Regurgitation in Patients With Left Ventricular Assist Devices (LVAD)","has_exemption":false,"start_date":"2024-12-09","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"JenaValve Technology, Inc.","sponsor_slug":"jenavalve-technology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06566742","publication_url":"https://clinicaltrials.gov/study/NCT06566742","title":"A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.","has_exemption":false,"start_date":"2024-12-10","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06695026","publication_url":"https://clinicaltrials.gov/study/NCT06695026","title":"A Phase 1b/2a, Open-label, Multicenter, Randomized, Dose Escalation Study Evaluating the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma","has_exemption":false,"start_date":"2024-12-18","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Rznomics, Inc.","sponsor_slug":"rznomics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06494150","publication_url":"https://clinicaltrials.gov/study/NCT06494150","title":"Phase II Study of Nab-sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer","has_exemption":false,"start_date":"2024-12-26","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06566079","publication_url":"https://clinicaltrials.gov/study/NCT06566079","title":"A Phase 1/2, Open-Label, Multicenter, FIH Study to Evaluate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Preliminary Efficacy of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors","has_exemption":false,"start_date":"2024-12-27","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"InSilico Medicine Hong Kong Limited","sponsor_slug":"insilico-medicine-hong-kong-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06672315","publication_url":"https://clinicaltrials.gov/study/NCT06672315","title":"Transesophageal Echocardiography in Pre-hospital Cardiac Arrest Patients; TAPCAP","has_exemption":false,"start_date":"2024-12-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Jen-Tang Sun","sponsor_slug":"jen-tang-sun","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06798896","publication_url":"https://clinicaltrials.gov/study/NCT06798896","title":"RENAISSANCE 2: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults With Focal Onset Seizures","has_exemption":false,"start_date":"2024-12-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Supernus Pharmaceuticals, Inc.","sponsor_slug":"supernus-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06559826","publication_url":"https://clinicaltrials.gov/study/NCT06559826","title":"A Randomized-Controlled Trial of Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression","has_exemption":false,"start_date":"2025-01-10","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06516653","publication_url":"https://clinicaltrials.gov/study/NCT06516653","title":"Postmarket Surveillance, Prospective, Multicenter, Randomized, Controlled Study Evaluating the Performance of VasQ for Its Intended Use.","has_exemption":false,"start_date":"2025-01-13","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Laminate Medical Technologies","sponsor_slug":"laminate-medical-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06544941","publication_url":"https://clinicaltrials.gov/study/NCT06544941","title":"Improving Maternal Mental Health in Military-Affiliated Pregnant Women: Effectiveness of a Smart Bassinet","has_exemption":false,"start_date":"2025-01-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Colorado Springs","sponsor_slug":"university-of-colorado-colorado-springs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06712121","publication_url":"https://clinicaltrials.gov/study/NCT06712121","title":"A Phase 2 Clinical Trial to Evaluate the Efficacy of VEnetoclax and DEciTabine in Relapsed/Refractory Adult T-acute Lymphoblastic lEukemia/Lymphoma","has_exemption":false,"start_date":"2025-01-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Seoul National University Hospital","sponsor_slug":"seoul-national-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06483555","publication_url":"https://clinicaltrials.gov/study/NCT06483555","title":"Subjects With Advanced Basal-like Pancreatic Adenocarcinoma Treated With Gemcitabine, Erlotinib and Nab-paclitaxel (PANGEA) Versus Subjects With Classical Pancreatic Adenocarcinoma Treated With Triplet Standard of Care Therapy.","has_exemption":false,"start_date":"2025-02-06","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06173713","publication_url":"https://clinicaltrials.gov/study/NCT06173713","title":"Multi-Center, Non-Controlled, Prospective Radiostereometric Analysis of Emphasys Hip Solutions","has_exemption":false,"start_date":"2025-02-11","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Canadian Radiostereometric Analysis Network","sponsor_slug":"canadian-radiostereometric-analysis-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06833112","publication_url":"https://clinicaltrials.gov/study/NCT06833112","title":"Efficacy and Safety of Interleukin-17 Inhibitor in Combination With Tumor Necrosis Factor α Inhibitor in the Treatment of Ankylosing Spondylitis","has_exemption":false,"start_date":"2025-02-28","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"The Affiliated Hospital Of Guizhou Medical University","sponsor_slug":"the-affiliated-hospital-of-guizhou-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06845202","publication_url":"https://clinicaltrials.gov/study/NCT06845202","title":"A Phase 1/2, Randomized, Double-blind, Placebo-controlled 2-part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-4324 in Overweight to Obese Adult Healthy Volunteers and Multiple Dose ALN-4324 in Overweight to Obese Patients With Type 2 Diabetes Mellitus (T2DM)","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06714253","publication_url":"https://clinicaltrials.gov/study/NCT06714253","title":"A Phase I/IIa, Dose Escalation Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Intraductal Administration of RXRG001 to Parotid Gland(s) in Adults With Radiation-Induced Xerostomia and Hyposalivation","has_exemption":false,"start_date":"2025-03-05","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"RiboX Therapeutics Ltd.","sponsor_slug":"ribox-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06864026","publication_url":"https://clinicaltrials.gov/study/NCT06864026","title":"A Phase 4, Prospective, Open-Label, Single-Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice.","has_exemption":false,"start_date":"2025-03-06","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06450925","publication_url":"https://clinicaltrials.gov/study/NCT06450925","title":"A Randomized Double Blinded Trial of Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.","has_exemption":false,"start_date":"2025-03-25","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06797258","publication_url":"https://clinicaltrials.gov/study/NCT06797258","title":"Safety And Effectiveness Of FlexHD® Pliable Acellular Dermal Matrix In Implant-Based Breast Reconstruction","has_exemption":false,"start_date":"2025-03-26","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Musculoskeletal Transplant Foundation","sponsor_slug":"musculoskeletal-transplant-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06718413","publication_url":"https://clinicaltrials.gov/study/NCT06718413","title":"Quantifying and Treating Myofascial Dysfunction in Post Stroke Shoulder Pain","has_exemption":false,"start_date":"2025-03-28","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06536049","publication_url":"https://clinicaltrials.gov/study/NCT06536049","title":"Phase Ib/II Trial of Epcoritamab Plus Ibrutinib in Patients With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2025-04-02","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Yazeed Sawalha","sponsor_slug":"yazeed-sawalha","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06191549","publication_url":"https://clinicaltrials.gov/study/NCT06191549","title":"Effect of Brain Stimulation on Locomotor Skill Acquisition in Stroke","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06967805","publication_url":"https://clinicaltrials.gov/study/NCT06967805","title":"A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)","has_exemption":false,"start_date":"2025-05-05","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Mediar Therapeutics","sponsor_slug":"mediar-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06885281","publication_url":"https://clinicaltrials.gov/study/NCT06885281","title":"A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors","has_exemption":false,"start_date":"2025-05-12","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Zai Lab (Shanghai) Co., Ltd.","sponsor_slug":"zai-lab-shanghai-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06402357","publication_url":"https://clinicaltrials.gov/study/NCT06402357","title":"Salvage Focal Therapy Via High Intensity Focused Ultrasound (HIFU) in Radiorecurrent Localized Prostate Cancer","has_exemption":false,"start_date":"2025-05-14","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06972459","publication_url":"https://clinicaltrials.gov/study/NCT06972459","title":"A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes","has_exemption":false,"start_date":"2025-05-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06993792","publication_url":"https://clinicaltrials.gov/study/NCT06993792","title":"A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes","has_exemption":false,"start_date":"2025-05-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06972472","publication_url":"https://clinicaltrials.gov/study/NCT06972472","title":"A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes","has_exemption":false,"start_date":"2025-05-19","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06976268","publication_url":"https://clinicaltrials.gov/study/NCT06976268","title":"A Phase 2/3, Double-Blind, Placebo-Controlled Study of BHV-8000 in Participants With Early Parkinson's Disease","has_exemption":false,"start_date":"2025-05-28","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Biohaven Therapeutics Ltd.","sponsor_slug":"biohaven-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06910163","publication_url":"https://clinicaltrials.gov/study/NCT06910163","title":"Direct-to-angio Approach From loCal hOspitals Based on a PoInt-of-care bLOod Test for LVO (COPILOT): an Effectiveness Cluster Randomized Crossover Trial","has_exemption":false,"start_date":"2025-05-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Juan Vicenty","sponsor_slug":"juan-vicenty","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06914609","publication_url":"https://clinicaltrials.gov/study/NCT06914609","title":"Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults With Angelman Syndrome","has_exemption":false,"start_date":"2025-06-10","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Ionis Pharmaceuticals, Inc.","sponsor_slug":"ionis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06880744","publication_url":"https://clinicaltrials.gov/study/NCT06880744","title":"Phase 3b, Multicenter, Randomized, Open-Label Study of Risankizumab Compared to Vedolizumab for the Treatment of Adult Subjects With Moderate to Severe Ulcerative Colitis Who Are Naïve to Targeted Therapies","has_exemption":false,"start_date":"2025-06-17","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06631209","publication_url":"https://clinicaltrials.gov/study/NCT06631209","title":"Effectiveness of Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep - Clinical Trial","has_exemption":false,"start_date":"2025-06-23","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07082738","publication_url":"https://clinicaltrials.gov/study/NCT07082738","title":"A Multicentre, Parallel-group, Phase IIb, Randomised, Double-blind, Placebo-controlled, 3-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO)","has_exemption":false,"start_date":"2025-06-27","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06835387","publication_url":"https://clinicaltrials.gov/study/NCT06835387","title":"Phase II Study of NALIRIFOX (Nanoliposomal Irinotecan + Oxaliplatin With Fluorouracil and Folinic Acid) in Advanced Unresectable Small Bowel Tumors","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Tiago Biachi de Castria","sponsor_slug":"tiago-biachi-de-castria","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07043946","publication_url":"https://clinicaltrials.gov/study/NCT07043946","title":"A Phase 1b/2a, Open-Label, Sequential-Cohort, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Effectiveness of Budoprutug (TNT119) in Subjects With Immune Thrombocytopenia (ITP)","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Climb Bio, Inc.","sponsor_slug":"climb-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06706232","publication_url":"https://clinicaltrials.gov/study/NCT06706232","title":"Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality","has_exemption":false,"start_date":"2025-07-07","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06898515","publication_url":"https://clinicaltrials.gov/study/NCT06898515","title":"Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II)","has_exemption":false,"start_date":"2025-07-28","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Reprieve Cardiovascular, Inc","sponsor_slug":"reprieve-cardiovascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06233344","publication_url":"https://clinicaltrials.gov/study/NCT06233344","title":"An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy","has_exemption":false,"start_date":"2025-07-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07111507","publication_url":"https://clinicaltrials.gov/study/NCT07111507","title":"TIDAL: Phase 2 Study of Tarlatamab in Patients With Delta-like Protein 3 (DLL3) Positive Metastatic Prostate Cancer","has_exemption":false,"start_date":"2025-07-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06584591","publication_url":"https://clinicaltrials.gov/study/NCT06584591","title":"Neuromodulation-Enhanced Use of RObotic Balance Training to Improve Postural Control in Individuals With Traumatic Brain Injury","has_exemption":false,"start_date":"2025-08-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Kessler Foundation","sponsor_slug":"kessler-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06865339","publication_url":"https://clinicaltrials.gov/study/NCT06865339","title":"TRIPL: Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2025-08-07","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07874763","publication_url":"https://clinicaltrials.gov/study/NCT07874763","title":"BACHmann Bundle Versus Right Atrial Appendage Pacing Randomized Controlled Trial: Learning Curve, Safety, Efficacy, Physiological Effect, and Transthoracic Echo Guidance","has_exemption":false,"start_date":"2025-08-19","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","sponsor_slug":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07177196","publication_url":"https://clinicaltrials.gov/study/NCT07177196","title":"An Open-label Single Center Study of an Individualized Antisense Oligonucleotide Treatment for Retinal Dystrophy Associated With a Pathogenic PRPH2 Variant","has_exemption":false,"start_date":"2025-08-28","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"n-Lorem Foundation","sponsor_slug":"n-lorem-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161518","publication_url":"https://clinicaltrials.gov/study/NCT07161518","title":"Characterizing Transcranial Focused Ultrasound Neuromodulation During Sedation","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07140783","publication_url":"https://clinicaltrials.gov/study/NCT07140783","title":"RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-MASKED STUDY OF THE SAFETY AND EFFICACY OF POS (0.75% PHENTOLAMINE OPHTHALMIC SOLUTION) IN PARTICIPANTS WITH PREVIOUS KERATOREFRACTIVE SURGERY WITH DECREASED VISUAL ACUITY UNDER MESOPIC CONDITIONS","has_exemption":false,"start_date":"2025-09-02","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Opus Genetics, Inc","sponsor_slug":"opus-genetics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06414590","publication_url":"https://clinicaltrials.gov/study/NCT06414590","title":"Neoadjuvant Tebentafusp in Patients With Locally Advanced, Unresectable Primary Uveal Melanoma","has_exemption":false,"start_date":"2025-09-05","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04750252","publication_url":"https://clinicaltrials.gov/study/NCT04750252","title":"An Open Label Study to Evaluate Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Akan Biosciences, LLC","sponsor_slug":"akan-biosciences-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096453","publication_url":"https://clinicaltrials.gov/study/NCT07096453","title":"CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients: a PK Pilot Study","has_exemption":false,"start_date":"2025-10-02","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07057323","publication_url":"https://clinicaltrials.gov/study/NCT07057323","title":"Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure With A Preserved Ejection Fraction Associated With Coronary Microvascular Dysfunction","has_exemption":false,"start_date":"2025-10-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07064798","publication_url":"https://clinicaltrials.gov/study/NCT07064798","title":"Evaluating the Use of Limb Cryocompression to Reduce Taxane-induced Peripheral Neuropathy","has_exemption":false,"start_date":"2025-10-22","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07123467","publication_url":"https://clinicaltrials.gov/study/NCT07123467","title":"Cannabidiol-Enhanced Cognitive Behavioral Therapy for Generalized Anxiety Disorder","has_exemption":false,"start_date":"2025-11-03","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Wayne State University","sponsor_slug":"wayne-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07145346","publication_url":"https://clinicaltrials.gov/study/NCT07145346","title":"Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-11-13","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284667","publication_url":"https://clinicaltrials.gov/study/NCT07284667","title":"A Double-Blind, Placebo-Controlled, Parallel Group, Efficacy and Safety Study of ACP-211 Monotherapy in Adults With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment","has_exemption":false,"start_date":"2025-11-14","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"ACADIA Pharmaceuticals Inc.","sponsor_slug":"acadia-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06811116","publication_url":"https://clinicaltrials.gov/study/NCT06811116","title":"A Phase I/II Trial of Sapanisertib in Combination With Cabozantinib in β-catenin-mutated Hepatocellular Carcinoma (SAPHIRE)","has_exemption":false,"start_date":"2025-11-17","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07087054","publication_url":"https://clinicaltrials.gov/study/NCT07087054","title":"A Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Paltusotine in Adults With Carcinoid Syndrome Due to Well-Differentiated Neuroendocrine Tumors","has_exemption":false,"start_date":"2025-11-19","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Crinetics Pharmaceuticals Inc.","sponsor_slug":"crinetics-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217873","publication_url":"https://clinicaltrials.gov/study/NCT07217873","title":"IntraVenous Iron in Kids With Iron Deficiency and Scoliosis","has_exemption":false,"start_date":"2025-11-21","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07129252","publication_url":"https://clinicaltrials.gov/study/NCT07129252","title":"A Phase 1/2 Dose Escalation Study of CRN09682 With an Expansion Phase in Participants With Progressive Metastatic Somatostatin Receptor Type 2 (SST2)-Expressing Neuroendocrine Neoplasms (NENs) and Other SST2-Expressing Solid Tumors","has_exemption":false,"start_date":"2025-11-26","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Crinetics Pharmaceuticals Inc.","sponsor_slug":"crinetics-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06991075","publication_url":"https://clinicaltrials.gov/study/NCT06991075","title":"A Randomized Controlled Trial of Transcutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07303907","publication_url":"https://clinicaltrials.gov/study/NCT07303907","title":"An Open-label Study Evaluating DT402 in Adults With Autism Spectrum Disorder","has_exemption":false,"start_date":"2025-12-03","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Definium Therapeutics US, Inc.","sponsor_slug":"definium-therapeutics-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07300969","publication_url":"https://clinicaltrials.gov/study/NCT07300969","title":"A Phase 2 Double-blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of DT-101 in Adults With Major Depressive Disorder (MDD)","has_exemption":false,"start_date":"2025-12-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Draig Therapeutics Ltd","sponsor_slug":"draig-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07346079","publication_url":"https://clinicaltrials.gov/study/NCT07346079","title":"A Randomized, Multicenter, Double-blind, Efficacy and Safety Study of 2 Dose Levels of Purified Cortrophin® Gel in Patients With Acute Gouty Arthritis Flares","has_exemption":false,"start_date":"2025-12-20","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07265479","publication_url":"https://clinicaltrials.gov/study/NCT07265479","title":"A Randomized, Double-Blind, Vehicle-Controlled (Period 1) and Open-Label (Period 2) Phase 3 Study to Investigate the Safety and Efficacy of Tapinarof Cream, 1% in Pediatric Participants Ages 3 Months to < 24 Months With Atopic Dermatitis","has_exemption":false,"start_date":"2025-12-29","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Organon and Co","sponsor_slug":"organon-and-co","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07111247","publication_url":"https://clinicaltrials.gov/study/NCT07111247","title":"Insights in Endocervical Mucus Secretion","has_exemption":false,"start_date":"2026-01-02","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06594068","publication_url":"https://clinicaltrials.gov/study/NCT06594068","title":"PRIMULA Lac (Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users): The AstraZeneca Lactation Study for Anifrolumab","has_exemption":false,"start_date":"2026-01-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07402954","publication_url":"https://clinicaltrials.gov/study/NCT07402954","title":"Feasibility and Safety of Endovascular Bipolar Stimulation of the Middle Meningeal Artery for Refractory Headaches (MMA-Stim)","has_exemption":false,"start_date":"2026-01-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281014","publication_url":"https://clinicaltrials.gov/study/NCT07281014","title":"Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing","has_exemption":false,"start_date":"2026-01-27","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281261","publication_url":"https://clinicaltrials.gov/study/NCT07281261","title":"Study of Transcutaneous Auricular Neurostimulation as a Treatment for Substance Use Disorder","has_exemption":false,"start_date":"2026-01-28","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Spark Biomedical, Inc.","sponsor_slug":"spark-biomedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06428448","publication_url":"https://clinicaltrials.gov/study/NCT06428448","title":"A Prospective, Multi-Center Study to Evaluate the Safety and Effectiveness of the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections","has_exemption":false,"start_date":"2026-02-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"OsteoRemedies, LLC","sponsor_slug":"osteoremedies-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07419854","publication_url":"https://clinicaltrials.gov/study/NCT07419854","title":"Restoring Facial Volume After GLP-1 Weight Loss With Radiesse","has_exemption":false,"start_date":"2026-02-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Kalpna Kay Durairaj, MD, FACS","sponsor_slug":"kalpna-kay-durairaj-md-facs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07357519","publication_url":"https://clinicaltrials.gov/study/NCT07357519","title":"A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, -Radiation Dosimetry, and Preliminary Anti-Neoplastic Activity of LNTH-2403, a LRRC15-targeted 177Lutetium-labeled Monoclonal Antibody, in Participants With Relapsed / Refractory Osteosarcoma","has_exemption":false,"start_date":"2026-02-03","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Lantheus Medical Imaging","sponsor_slug":"lantheus-medical-imaging","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288333","publication_url":"https://clinicaltrials.gov/study/NCT07288333","title":"A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117570 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization","has_exemption":false,"start_date":"2026-02-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Neurocrine Biosciences","sponsor_slug":"neurocrine-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07454837","publication_url":"https://clinicaltrials.gov/study/NCT07454837","title":"A Phase 2b/3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelovitug for the Treatment of Chronic Hepatitis Delta Infection in Participants Receiving Bulevirtide (AZURE-3)","has_exemption":false,"start_date":"2026-02-26","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Mirum Pharmaceuticals, Inc.","sponsor_slug":"mirum-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07351227","publication_url":"https://clinicaltrials.gov/study/NCT07351227","title":"Comparison of the Effectiveness and Cost-Effectiveness of McGRATH™ MAC and Besdata Videolaryngoscopes in the Orotracheal Intubation of Children: A Non-Inferiority Randomized Clinical Trial","has_exemption":false,"start_date":"2026-03-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Sao Paulo General Hospital","sponsor_slug":"university-of-sao-paulo-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07326722","publication_url":"https://clinicaltrials.gov/study/NCT07326722","title":"Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding: The LUNA Study","has_exemption":false,"start_date":"2026-03-06","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Spark Biomedical, Inc.","sponsor_slug":"spark-biomedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05991700","publication_url":"https://clinicaltrials.gov/study/NCT05991700","title":"Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation","has_exemption":false,"start_date":"2026-03-23","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07323862","publication_url":"https://clinicaltrials.gov/study/NCT07323862","title":"Spatially Transparent Binaural Beamforming for Noise Reduction for Cochlear Implant Processors","has_exemption":false,"start_date":"2026-04-27","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Urbana-Champaign","sponsor_slug":"university-of-illinois-at-urbana-champaign","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05646524","publication_url":"https://clinicaltrials.gov/study/NCT05646524","title":"A Phase II, Open-Label Study of NM8074 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"NovelMed Therapeutics","sponsor_slug":"novelmed-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07552077","publication_url":"https://clinicaltrials.gov/study/NCT07552077","title":"A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Palvella Therapeutics, Inc.","sponsor_slug":"palvella-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07362862","publication_url":"https://clinicaltrials.gov/study/NCT07362862","title":"Safety and Feasibility of the MyokinE100 System in ICU Settings to Mitigate ICU Acquired Weakness","has_exemption":false,"start_date":"2026-05-05","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Health Discovery Labs","sponsor_slug":"health-discovery-labs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07401186","publication_url":"https://clinicaltrials.gov/study/NCT07401186","title":"Stimulation Evoked Primary Afferent Depolarization to Modulate Sensory Transmission to Spinal Motoneurons and the Sensory Cortex","has_exemption":false,"start_date":"2026-05-26","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Peter C. Gerszten, MD","sponsor_slug":"peter-c-gerszten-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07348614","publication_url":"https://clinicaltrials.gov/study/NCT07348614","title":"Flex Appeal: A Prospective Randomized Controlled Trial Evaluating the Efficacy of Anesthetic Techniques for Manipulation of Knees Under Anesthesia (MUA)","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07410455","publication_url":"https://clinicaltrials.gov/study/NCT07410455","title":"An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Can-Fite BioPharma","sponsor_slug":"can-fite-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07489885","publication_url":"https://clinicaltrials.gov/study/NCT07489885","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate to Severe Plaque Psoriasis","has_exemption":false,"start_date":"2026-06-03","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"InventisBio Co., Ltd","sponsor_slug":"inventisbio-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07498270","publication_url":"https://clinicaltrials.gov/study/NCT07498270","title":"Location- and Frequency-Dependent Effects of Thalamic Temporal Interference Stimulation During Sleep","has_exemption":false,"start_date":"2026-06-05","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06015607","publication_url":"https://clinicaltrials.gov/study/NCT06015607","title":"Testing of GripTract-GI Endoscopic Tissue Manipulator for Use During Complex Endoscopic Polypectomies in the Colon","has_exemption":false,"start_date":"2026-06-11","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Actuated Medical, Inc.","sponsor_slug":"actuated-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07645287","publication_url":"https://clinicaltrials.gov/study/NCT07645287","title":"A Phase 2 Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Injectable Regimen of GS-3242 in Combination With Lenacapavir Versus Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) in Virologically Suppressed People With HIV-1","has_exemption":false,"start_date":"2026-06-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07324031","publication_url":"https://clinicaltrials.gov/study/NCT07324031","title":"Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study","has_exemption":false,"start_date":"2026-07-02","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"AtaCor Medical, Inc.","sponsor_slug":"atacor-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07003295","publication_url":"https://clinicaltrials.gov/study/NCT07003295","title":"A Phase II Study of Glofitamab for Relapsed/Refractory Mantle Cell Lymphoma in Patients Previously Treated With CD19-Directed CAR T-Cell Therapy","has_exemption":false,"start_date":"2026-07-08","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07662720","publication_url":"https://clinicaltrials.gov/study/NCT07662720","title":"A Phase I/II, Open-Label, Study to Assess the Safety, Tolerability, and Efficacy of Axelopran Administered With Standard of Care Pembrolizumab in Recurrent/Metastatic HNSCC Patients Taking Opioids to Control Cancer Pain","has_exemption":false,"start_date":"2026-07-15","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Glycyx Therapeutics","sponsor_slug":"glycyx-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07560618","publication_url":"https://clinicaltrials.gov/study/NCT07560618","title":"A Phase 4, Open Label Study to Assess Descriptive Classification of Pruritus Over Time With Roflumilast 0.15% Cream in Patients With Atopic Dermatitis","has_exemption":false,"start_date":"2026-07-21","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Integrative Skin Science and Research","sponsor_slug":"integrative-skin-science-and-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07641179","publication_url":"https://clinicaltrials.gov/study/NCT07641179","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MAR002 in Participants With Acromegaly (TROUGH-2)","has_exemption":false,"start_date":"2026-07-23","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Marea Therapeutics","sponsor_slug":"marea-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07690657","publication_url":"https://clinicaltrials.gov/study/NCT07690657","title":"Evaluating Intervention Allocation Policies for Reducing Hospital Readmissions at Michigan Medicine","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07654751","publication_url":"https://clinicaltrials.gov/study/NCT07654751","title":"A Phase 4, Open-Label, Milk-Only Lactation Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically","has_exemption":false,"start_date":"2026-08-07","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07759817","publication_url":"https://clinicaltrials.gov/study/NCT07759817","title":"Safety and Efficacy of a 2,910 nm Fractional Ablative Fiber Laser (UltraClear®) for Improvements of Skin Laxity and Lifting of the Lower Face, Submental, and Neck Treatment Areas","has_exemption":false,"start_date":"2026-08-07","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"FA Corporation","sponsor_slug":"fa-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07610746","publication_url":"https://clinicaltrials.gov/study/NCT07610746","title":"Early Detection of Neonatal Opioid Withdrawal Syndrome Using a Novel Cerebral Monitor.","has_exemption":false,"start_date":"2026-08-11","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07710469","publication_url":"https://clinicaltrials.gov/study/NCT07710469","title":"A Randomized Controlled Trial of a Hospital-Grade Weighted Blanket to Improve Sedation Quality During Ventilator Weaning in the Blake 7 MICU (MGH)","has_exemption":false,"start_date":"2026-08-17","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07668882","publication_url":"https://clinicaltrials.gov/study/NCT07668882","title":"Noninvasive Thalamocortical Neuromodulation With Low-Intensity Focused Ultrasound for Persistent Developmental Stuttering","has_exemption":false,"start_date":"2026-08-19","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07191873","publication_url":"https://clinicaltrials.gov/study/NCT07191873","title":"A Phase IV Placebo-controlled Single Center Trial for Tirzepatide in Idiopathic Intracranial Hypertension Trial (TIIHT)","has_exemption":false,"start_date":"2026-08-25","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06792474","publication_url":"https://clinicaltrials.gov/study/NCT06792474","title":"Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds; a Single-center, Double-blinded, Randomized Trial for Patients Undergoing Spin Surgery With Intraoperative Neurophysiologic Monitoring.","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07582484","publication_url":"https://clinicaltrials.gov/study/NCT07582484","title":"Phase 1/2b Gene Transfer Clinical Trial for Variant Late Infantile Neuronal Ceroid Lipofuscinosis (CLN6 Batten Disease), Delivering the CLN6 Gene by Self-Complementary AAV9","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"The Charlotte and Gwenyth Gray Foundation","sponsor_slug":"the-charlotte-and-gwenyth-gray-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07714759","publication_url":"https://clinicaltrials.gov/study/NCT07714759","title":"A Study Comparing Continuous Glucose Monitoring Augmented Nutritional Counseling and Standard of Care Treatment Strategies in a Three-Month Nutrition Intervention","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07722728","publication_url":"https://clinicaltrials.gov/study/NCT07722728","title":"An Open-label, Randomized, Single-dose (Long-acting Injectable) or Multiple-dose (Oral) Clinical Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in Participants With Schizophrenia","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Bostal Drug Delivery Co., Ltd","sponsor_slug":"bostal-drug-delivery-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07742280","publication_url":"https://clinicaltrials.gov/study/NCT07742280","title":"An Open-Label, Multi-Center Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Brexpiprazole for Extended-Release Injection Administered as a Single Dose in Subjects With Schizophrenia","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Bostal Drug Delivery Co., Ltd","sponsor_slug":"bostal-drug-delivery-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07151417","publication_url":"https://clinicaltrials.gov/study/NCT07151417","title":"Adjunctive Use of Corticosteroid in Periarticular Injections in Primary Total Knee Arthroplasty","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Walter Reed National Military Medical Center","sponsor_slug":"walter-reed-national-military-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07537413","publication_url":"https://clinicaltrials.gov/study/NCT07537413","title":"Pragmatic Randomized Trial Evaluating Dosage of Ceftriaxone for Community-Acquired Pneumonia Outside the Intensive Care Unit","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07499999","publication_url":"https://clinicaltrials.gov/study/NCT07499999","title":"Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer (BabyTEARS)","has_exemption":false,"start_date":"2026-09-09","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07782333","publication_url":"https://clinicaltrials.gov/study/NCT07782333","title":"A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Multiple Subcutaneous Doses of TRIV-573 in Participants With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2026-09-09","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Triveni Bio","sponsor_slug":"triveni-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07587021","publication_url":"https://clinicaltrials.gov/study/NCT07587021","title":"A Randomized, Double-blind, Placebo-controlled Study Followed by a Treatment Extension to Evaluate the Efficacy and Safety of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1","has_exemption":false,"start_date":"2026-09-16","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"YolTech Therapeutics Co., Ltd","sponsor_slug":"yoltech-therapeutics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07676578","publication_url":"https://clinicaltrials.gov/study/NCT07676578","title":"Investigating the Feasibility and Translational Therapeutic Benefits of Overground, Fully Immersive Virtual Reality (VR) Gait Rehabilitation Therapies for Stroke Survivors","has_exemption":false,"start_date":"2026-09-18","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07140497","publication_url":"https://clinicaltrials.gov/study/NCT07140497","title":"Reduction of Anxiety Through Dual Mental Health Treatment: Digital-Based Cognitive Behavioral Therapy and National Board for Health and Wellness Coaching (NBHWC) Mental Health Coaches","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Toivoa Inc","sponsor_slug":"toivoa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07195292","publication_url":"https://clinicaltrials.gov/study/NCT07195292","title":"Reduction of Depression Through Dual Mental Health Treatment: Digital-Based Cognitive Behavioral Therapy and National Board for Health and Wellness Coaching (NBHWC) Mental Health Coaches","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Toivoa Inc","sponsor_slug":"toivoa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07822321","publication_url":"https://clinicaltrials.gov/study/NCT07822321","title":"A Randomized, Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Lipocine Inc.","sponsor_slug":"lipocine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07839715","publication_url":"https://clinicaltrials.gov/study/NCT07839715","title":"Evaluation of Suzetrigine Within an ERAS Protocol for DIEP Flap Breast Reconstruction: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07868419","publication_url":"https://clinicaltrials.gov/study/NCT07868419","title":"A Randomized, Double-Blind, Placebo-Controlled Twelve-Week Fixed-Dose Study to Evaluate the Efficacy and Safety of Nalbuphine Extended-Release Tablets for the Treatment of Chronic Cough in Participants With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Trevi Therapeutics","sponsor_slug":"trevi-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06580405","publication_url":"https://clinicaltrials.gov/study/NCT06580405","title":"A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Patients With Preeclampsia With Severe Features","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Kaneka Medical America LLC","sponsor_slug":"kaneka-medical-america-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07841990","publication_url":"https://clinicaltrials.gov/study/NCT07841990","title":"A Platform, Active-Controlled Study Evaluating the Safety and Efficacy of Long-Acting Oral Regimens in People With HIV-1; Substudy-01: Phase 2, Open-Label, Weekly, Long-Acting, Oral Regimens in Virologically Suppressed People With HIV-1","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07631650","publication_url":"https://clinicaltrials.gov/study/NCT07631650","title":"A Phase 2 Trial of Systemic Administration of Bevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Patients Undergoing Thyroidectomy","has_exemption":false,"start_date":"2026-10-18","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Matthew Spector","sponsor_slug":"matthew-spector","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07542314","publication_url":"https://clinicaltrials.gov/study/NCT07542314","title":"Phase 4 Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Patients With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting (ENHANCE)","has_exemption":false,"start_date":"2026-10-30","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Sarepta Therapeutics, Inc.","sponsor_slug":"sarepta-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07526974","publication_url":"https://clinicaltrials.gov/study/NCT07526974","title":"A Phase 3, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat.","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","sponsor_slug":"caliway-biopharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07674784","publication_url":"https://clinicaltrials.gov/study/NCT07674784","title":"Clinical Interventions to Acutely Enhance Quadriceps Output After Anterior Cruciate Ligament Reconstruction","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07729137","publication_url":"https://clinicaltrials.gov/study/NCT07729137","title":"A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 2 Study of EO2002 in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction (EMERALD)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Emmecell","sponsor_slug":"emmecell","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07735611","publication_url":"https://clinicaltrials.gov/study/NCT07735611","title":"Robotic Systems Evaluation for Peripheral Pulmonary Lesions: A Randomized Trial (RISE Trial)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07750678","publication_url":"https://clinicaltrials.gov/study/NCT07750678","title":"A Multicenter, Phase I/II, Clinical Study to Evaluate the Safety, Tolerability and Efficacy of Intrastromal Injection of Genome-editing GEB-101 in Participants With TGFBI-related Corneal Dystrophy","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"GenEditBio Limited","sponsor_slug":"geneditbio-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07796256","publication_url":"https://clinicaltrials.gov/study/NCT07796256","title":"A Multicenter, Randomized, Open-Label Phase II Study to Evaluate the Efficacy and Safety of Multiple Doses of SGB-9768 in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Suzhou Sanegene Bio Inc.","sponsor_slug":"suzhou-sanegene-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07792226","publication_url":"https://clinicaltrials.gov/study/NCT07792226","title":"A Single-center Randomized Controlled Trial Evaluating Whether Adding Fundal Mucosal Ablation (FMA) to Standard Endoscopic Sleeve Gastroplasty (ESG) Leads to Greater Weight Loss, Improved Obesity-related Comorbidities, and Better Metabolic and Hormonal Outcomes Compared With ESG Alone in Adults With Obesity.","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07856797","publication_url":"https://clinicaltrials.gov/study/NCT07856797","title":"A Prospective, Open-Label, Multicenter, Post-Market Clinical Follow-Up Study to Confirm the Long-term Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Merz North America, Inc.","sponsor_slug":"merz-north-america-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07863193","publication_url":"https://clinicaltrials.gov/study/NCT07863193","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Design Trial to Evaluate the Safety and Efficacy of Denifanstat in Participants With Moderate to Severe Acne Vulgaris","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Sagimet Biosciences Inc.","sponsor_slug":"sagimet-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07866105","publication_url":"https://clinicaltrials.gov/study/NCT07866105","title":"A Phase 2b, Randomized, Double-Blind, Vehicle-Controlled Multi-Center Study of the Efficacy, Safety, and Tolerability of B244 Delivered as a Topical Spray in the Treatment of Moderate to Severe Acne Vulgaris","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"AOBiome LLC","sponsor_slug":"aobiome-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07856134","publication_url":"https://clinicaltrials.gov/study/NCT07856134","title":"A Phase 4, Prospective, Multicenter, Single-Arm, Pragmatic Interventional Cohort Study Evaluating Real-World Outcomes and Dosing Patterns of Ebglyss (Lebrikizumab) in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis","has_exemption":false,"start_date":"2026-11-11","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Forefront Dermatology S.C","sponsor_slug":"forefront-dermatology-sc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07439666","publication_url":"https://clinicaltrials.gov/study/NCT07439666","title":"The Role of NEUROCUPLE™ as an Alternative to Opioids Following Total Knee Arthroplasty Patients","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Jacques E. Chelly","sponsor_slug":"jacques-e-chelly","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07444541","publication_url":"https://clinicaltrials.gov/study/NCT07444541","title":"A Phase Ib/Ⅱ Clinical Study to Evaluate the Safety and Efficacy of ANO31905 for Injection in Combination With Chemotherapy as the First-line Treatment for Patients With CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Anova Innovation Limited","sponsor_slug":"anova-innovation-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07661979","publication_url":"https://clinicaltrials.gov/study/NCT07661979","title":"Opzelura Experience Study","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07819474","publication_url":"https://clinicaltrials.gov/study/NCT07819474","title":"Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With","has_exemption":false,"start_date":"2027-02-18","completion_date":"2027-08-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02839850","publication_url":"https://clinicaltrials.gov/study/NCT02839850","title":"Multi-Center Clinical Evaluation of the ATTUNE Cementless Rotating Platform Total Knee Arthroplasty","has_exemption":false,"start_date":"2016-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"DePuy Orthopaedics","sponsor_slug":"depuy-orthopaedics","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02978625","publication_url":"https://clinicaltrials.gov/study/NCT02978625","title":"A Phase II Study of Talimogene Laherparepvec Followed by Talimogene Laherparepvec + Nivolumab in Refractory T Cell and NK Cell Lymphomas, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, and Other Rare Skin Tumors","has_exemption":false,"start_date":"2017-09-27","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03470480","publication_url":"https://clinicaltrials.gov/study/NCT03470480","title":"The Use of Repetitive Transmagnetic Stimulation to Target Craving in Methamphetamine Use Disorder","has_exemption":false,"start_date":"2018-02-07","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03488693","publication_url":"https://clinicaltrials.gov/study/NCT03488693","title":"TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer","has_exemption":false,"start_date":"2018-10-16","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Canadian Cancer Trials Group","sponsor_slug":"canadian-cancer-trials-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03821623","publication_url":"https://clinicaltrials.gov/study/NCT03821623","title":"Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults","has_exemption":false,"start_date":"2019-05-10","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Douglas Seals","sponsor_slug":"douglas-seals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04991389","publication_url":"https://clinicaltrials.gov/study/NCT04991389","title":"Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics","has_exemption":false,"start_date":"2019-08-15","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04047264","publication_url":"https://clinicaltrials.gov/study/NCT04047264","title":"Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions","has_exemption":false,"start_date":"2020-01-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04234061","publication_url":"https://clinicaltrials.gov/study/NCT04234061","title":"A Phase II, Open-Label, Single Arm Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma","has_exemption":false,"start_date":"2020-04-07","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Peter MacCallum Cancer Centre, Australia","sponsor_slug":"peter-maccallum-cancer-centre-australia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04253964","publication_url":"https://clinicaltrials.gov/study/NCT04253964","title":"Phase II Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-Small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy","has_exemption":false,"start_date":"2020-07-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03696199","publication_url":"https://clinicaltrials.gov/study/NCT03696199","title":"A Prospective, Randomized Trial Evaluating Regional Anesthesia, Long-Acting Local Anesthesia, and Traditional Care for Pain Control of Operatively Treated Ankle Fractures","has_exemption":false,"start_date":"2020-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Lahey Clinic","sponsor_slug":"lahey-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06617845","publication_url":"https://clinicaltrials.gov/study/NCT06617845","title":"Optimizing Brain Stimulation Parameters","has_exemption":false,"start_date":"2020-10-20","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04776395","publication_url":"https://clinicaltrials.gov/study/NCT04776395","title":"Iberdomide in Intermediate- and High-Risk Smoldering Myeloma (SMM) Patients: A Phase 2 Study With a Safety Run-in","has_exemption":false,"start_date":"2021-07-09","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05023772","publication_url":"https://clinicaltrials.gov/study/NCT05023772","title":"A Clinical Trial Evaluating the Efficacy of Combining Laser Interstitial Thermal Ablation With and Without Spine Stereotactic Radiosurgery for Patients With Spine Metastases","has_exemption":false,"start_date":"2021-09-02","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05266417","publication_url":"https://clinicaltrials.gov/study/NCT05266417","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Evaluate the Safety, Tolerability, and Efficacy of Intranasal Insulin and Glutathione as an Add-On Therapy in Subjects With Parkinson's Disease (NOSE-PD)","has_exemption":false,"start_date":"2022-02-07","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Gateway Institute for Brain Research","sponsor_slug":"gateway-institute-for-brain-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05310448","publication_url":"https://clinicaltrials.gov/study/NCT05310448","title":"Tumor Treating Fields: Pilot Study of Adjuvant Treatment for Brainstem Gliomas","has_exemption":false,"start_date":"2022-05-11","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05268094","publication_url":"https://clinicaltrials.gov/study/NCT05268094","title":"Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)","has_exemption":false,"start_date":"2022-06-02","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Carelon Research","sponsor_slug":"carelon-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05553457","publication_url":"https://clinicaltrials.gov/study/NCT05553457","title":"MyHand-SCI: A Wearable Robotic Hand Orthosis for C6-C7 Spinal Cord Injury","has_exemption":false,"start_date":"2022-10-04","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05629585","publication_url":"https://clinicaltrials.gov/study/NCT05629585","title":"A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (DatoDXd) With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)","has_exemption":false,"start_date":"2022-11-28","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669755","publication_url":"https://clinicaltrials.gov/study/NCT05669755","title":"The Cardiovascular Safety and Efficacy of Cagrilintide 2.4 mg s.c. in Combination With Semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) Once-weekly in Participants With Established Cardiovascular Disease","has_exemption":false,"start_date":"2023-03-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05851924","publication_url":"https://clinicaltrials.gov/study/NCT05851924","title":"Total Neoadjuvant NALIRIFOX Plus Ablative Dose Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2023-05-12","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05224401","publication_url":"https://clinicaltrials.gov/study/NCT05224401","title":"Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in Febrile UTIs Caused by ESBL-producing Enterobacterales (PACUTI)","has_exemption":false,"start_date":"2023-05-29","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Lund University","sponsor_slug":"lund-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07105475","publication_url":"https://clinicaltrials.gov/study/NCT07105475","title":"Randomized, Sham Controlled Study for the Treatment of ADHD Using High and Low Frequency Paired Associative Deep Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2023-07-19","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Ben-Gurion University of the Negev","sponsor_slug":"ben-gurion-university-of-the-negev","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05380856","publication_url":"https://clinicaltrials.gov/study/NCT05380856","title":"Sacral Neuromodulation for Patients With Multiple Sclerosis With Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction. A Multicenter Double-blind, Placebo-controlled Randomized Clinical Trial.","has_exemption":false,"start_date":"2023-08-18","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Odense University Hospital","sponsor_slug":"odense-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05931393","publication_url":"https://clinicaltrials.gov/study/NCT05931393","title":"Phase 2, Open-label, Single Cohort, Multicenter Trial for Sequential Treatment of High Dose Cabozantinib on/After Progression on Cabozantinib Monotherapy in Advanced Renal Cell Carcinoma (Seq-Cabo)","has_exemption":false,"start_date":"2023-12-20","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04939051","publication_url":"https://clinicaltrials.gov/study/NCT04939051","title":"Obeticholic Acid for Prevention in Barrett's Esophagus","has_exemption":false,"start_date":"2024-01-03","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05987852","publication_url":"https://clinicaltrials.gov/study/NCT05987852","title":"Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial","has_exemption":false,"start_date":"2024-01-09","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06172478","publication_url":"https://clinicaltrials.gov/study/NCT06172478","title":"HERTHENA-PanTumor01 (U31402-277): A Phase 2, Multicenter, Multicohort, Open-Label, Proof of Concept Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Subjects With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2024-02-26","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06143566","publication_url":"https://clinicaltrials.gov/study/NCT06143566","title":"Polypill Strategy for Prevention of Cardiomyopathy Among Patients With Diabetes at Risk of Heart Failure","has_exemption":false,"start_date":"2024-03-11","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06818474","publication_url":"https://clinicaltrials.gov/study/NCT06818474","title":"Lanadelumab in Long-term Prophylaxis of Acquired Angioedema","has_exemption":false,"start_date":"2024-06-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Bernstein Clinical Research Center","sponsor_slug":"bernstein-clinical-research-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06228066","publication_url":"https://clinicaltrials.gov/study/NCT06228066","title":"A Phase II Study of Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)","has_exemption":false,"start_date":"2024-06-13","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06369246","publication_url":"https://clinicaltrials.gov/study/NCT06369246","title":"PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.","has_exemption":false,"start_date":"2024-06-27","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06465966","publication_url":"https://clinicaltrials.gov/study/NCT06465966","title":"UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning","has_exemption":false,"start_date":"2024-09-23","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06366347","publication_url":"https://clinicaltrials.gov/study/NCT06366347","title":"A Phase 2 Trial of Maintenance Abemaciclib/Letrozole After Systemic Therapy in Patients With Advanced or Recurrent Estrogen Receptor Positive, Mismatch Repair Proficient, TP53 Wildtype Endometrial Cancer","has_exemption":false,"start_date":"2024-09-25","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06377540","publication_url":"https://clinicaltrials.gov/study/NCT06377540","title":"MT2022-60: A Phase II Study of Pembrolizumab+ BEAM Conditioning Regimen Before Autologous Stem Cell Transplant (ASCT) Followed by Pembrolizumab Maintenance in Patients of Relapsed or Refractory Classic Hodgkin Lymphoma","has_exemption":false,"start_date":"2024-12-04","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06657924","publication_url":"https://clinicaltrials.gov/study/NCT06657924","title":"Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery","has_exemption":false,"start_date":"2025-02-11","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Kristen Ban","sponsor_slug":"kristen-ban","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06686680","publication_url":"https://clinicaltrials.gov/study/NCT06686680","title":"Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy","has_exemption":false,"start_date":"2025-04-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Spaulding Rehabilitation Hospital","sponsor_slug":"spaulding-rehabilitation-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06716580","publication_url":"https://clinicaltrials.gov/study/NCT06716580","title":"EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations","has_exemption":false,"start_date":"2025-04-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06639464","publication_url":"https://clinicaltrials.gov/study/NCT06639464","title":"Semaglutide for the Treatment of Opioid Use Disorder: A Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2025-06-02","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05134311","publication_url":"https://clinicaltrials.gov/study/NCT05134311","title":"Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies","has_exemption":false,"start_date":"2025-07-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212036","publication_url":"https://clinicaltrials.gov/study/NCT07212036","title":"The Utilization of Ultrasound to Diagnose Pediatric Elbow Fractures: Evaluation of Cost Savings, Radiation Exposure, and Patient Satisfaction","has_exemption":false,"start_date":"2025-07-22","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Nemours Children's Clinic","sponsor_slug":"nemours-childrens-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06947902","publication_url":"https://clinicaltrials.gov/study/NCT06947902","title":"Optimizing High Flow Nasal Cannula Oxygenation in Pediatric Airway Procedures: a Randomized Study","has_exemption":false,"start_date":"2025-08-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04521972","publication_url":"https://clinicaltrials.gov/study/NCT04521972","title":"Impact of Light on Labor Progression","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Michigan State University","sponsor_slug":"michigan-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06658002","publication_url":"https://clinicaltrials.gov/study/NCT06658002","title":"Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06801431","publication_url":"https://clinicaltrials.gov/study/NCT06801431","title":"A Pilot Study on the Tolerance, Feasibility, and Impact of Transcutaneous Spinal Cord Stimulation on Bowel Management in Individuals with Motor Complete Spinal Cord Injury Receiving Inpatient Care","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Nova Scotia Health Authority","sponsor_slug":"nova-scotia-health-authority","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06871787","publication_url":"https://clinicaltrials.gov/study/NCT06871787","title":"Evaluation of Bowel Anastomoses During Gynecologic Oncology Surgery Using Near-Infrared Fluorescence Imaging With Indocyanine Green","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Istanbul University","sponsor_slug":"istanbul-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07388342","publication_url":"https://clinicaltrials.gov/study/NCT07388342","title":"Diagnostic Accuracy of ECG-less Gated Cardiac CT in Resuscitated Cardiac Arrest Survivors","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Universitair Ziekenhuis Brussel","sponsor_slug":"universitair-ziekenhuis-brussel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06850402","publication_url":"https://clinicaltrials.gov/study/NCT06850402","title":"Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care","has_exemption":false,"start_date":"2025-09-22","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07104084","publication_url":"https://clinicaltrials.gov/study/NCT07104084","title":"Comparison of Wound Healing Complications After Anterior Total Hip Arthroplasty Using Povidone-iodine or Chlorhexidine as Antiseptic Wash","has_exemption":false,"start_date":"2025-10-09","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"F. Johannes Plate","sponsor_slug":"f-johannes-plate","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07406295","publication_url":"https://clinicaltrials.gov/study/NCT07406295","title":"Novel Respiratory Muscle Training for Improving Cerebrovascular Function and Immune Status in Adults With Obesity","has_exemption":false,"start_date":"2026-01-27","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Florida State University","sponsor_slug":"florida-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07516327","publication_url":"https://clinicaltrials.gov/study/NCT07516327","title":"Cold and Compression After Rotator Cuff Repair or Arthroscopic Rotator Cuff Repair Pain Attenuation: A Randomized, Controlled Trial","has_exemption":false,"start_date":"2026-03-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Ochsner Health System","sponsor_slug":"ochsner-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06997965","publication_url":"https://clinicaltrials.gov/study/NCT06997965","title":"An Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to Crohn's Disease","has_exemption":false,"start_date":"2026-04-20","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Alimentiv Inc.","sponsor_slug":"alimentiv-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727305","publication_url":"https://clinicaltrials.gov/study/NCT06727305","title":"Characterization of mTOR Inhibitor Pharmacokinetics and Pharmacodynamics in Older Adults .","has_exemption":false,"start_date":"2026-05-11","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07696273","publication_url":"https://clinicaltrials.gov/study/NCT07696273","title":"Miniaturized Smart Sensor Device for the Detection of Hypo- and Hyperglycemic Events in Persons Diagnosed With Diabetes","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07654842","publication_url":"https://clinicaltrials.gov/study/NCT07654842","title":"Fasenra Demonstrates Durability Over the Full 8-week Treatment Period","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Endeavor Health","sponsor_slug":"endeavor-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07139405","publication_url":"https://clinicaltrials.gov/study/NCT07139405","title":"A Double-Blind, Randomized, Active-Controlled Phase 2a Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of TriGlytza®-01 in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Myopharm Limited","sponsor_slug":"myopharm-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07693166","publication_url":"https://clinicaltrials.gov/study/NCT07693166","title":"Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF (SHIELD-RSV)","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"University of British Columbia","sponsor_slug":"university-of-british-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07704775","publication_url":"https://clinicaltrials.gov/study/NCT07704775","title":"Nemolizumab for the Treatment of Lichen Sclerosus","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07714005","publication_url":"https://clinicaltrials.gov/study/NCT07714005","title":"Combining Transcranial Magnetic Stimulation With Emotion Regulation Skills Training in Borderline Personality Disorder","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07840105","publication_url":"https://clinicaltrials.gov/study/NCT07840105","title":"A Phase 2, Randomized, Open-Label, Multicentre, Comparative 3 Arm Study to Evaluate the Efficacy And Safety of Intravenous Ertapenem-zidebactam Versus Ceftazidime-Avibactam in the Treatment of Complicated Urinary Tract Infection or Acute Pyelonephritis in Adults","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Wockhardt","sponsor_slug":"wockhardt","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07384767","publication_url":"https://clinicaltrials.gov/study/NCT07384767","title":"Efficacy and Safety of Topical Timolol in the Treatment of Cutaneous Surgical Wounds Left to Heal by Secondary Intention","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07565974","publication_url":"https://clinicaltrials.gov/study/NCT07565974","title":"MC251001 - Phase II Randomized Double-Blinded Pilot Study of THC vs. THC/CBD (1:1) vs. Placebo for Insomnia in Patients With Cancer","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06693752","publication_url":"https://clinicaltrials.gov/study/NCT06693752","title":"Pilot Study of Improved Diagnosis and Monitoring of Hydrocephalus in Neonates and Infants Using Contrast-Enhanced Ultrasound","has_exemption":false,"start_date":"2026-10-15","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07878390","publication_url":"https://clinicaltrials.gov/study/NCT07878390","title":"A Randomized Split-Wound Clinical Trial Comparing SYLKE Silk Fibroin Dressing to Standard Adhesive Dressings in Abdominoplasty and Panniculectomy Patients","has_exemption":false,"start_date":"2026-11-01","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07791498","publication_url":"https://clinicaltrials.gov/study/NCT07791498","title":"A Phase 2 Study of Teclistamab in Relapsed or Refractory Waldenstrom's Macroglobulinemia","has_exemption":false,"start_date":"2027-02-19","completion_date":"2027-09-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04544111","publication_url":"https://clinicaltrials.gov/study/NCT04544111","title":"Phase II Study of PDR001 in Combination With MAPK Pathway Inhibitors in Patients With Radioiodine-Refractory Thyroid Cancer","has_exemption":false,"start_date":"2020-09-02","completion_date":"2027-09-02","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04925479","publication_url":"https://clinicaltrials.gov/study/NCT04925479","title":"A Multi-center, Open-label Study to Determine the Dose and Safety of Oral Asciminib in Pediatric Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP), Previously Treated With One or More Tyrosine Kinase Inhibitors","has_exemption":false,"start_date":"2021-12-27","completion_date":"2027-09-02","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06085729","publication_url":"https://clinicaltrials.gov/study/NCT06085729","title":"Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)","has_exemption":false,"start_date":"2024-02-29","completion_date":"2027-09-02","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05218447","publication_url":"https://clinicaltrials.gov/study/NCT05218447","title":"Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury","has_exemption":false,"start_date":"2022-05-20","completion_date":"2027-09-03","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06508749","publication_url":"https://clinicaltrials.gov/study/NCT06508749","title":"Phase I/II Trial to Evaluate the Impact of Three Broadly Neutralizing Antibodies or Analytic Treatment Interruption on Viral Reservoir, Immune Function, and Maintenance of HIV Suppression in Early Treated Children in Botswana","has_exemption":false,"start_date":"2024-11-11","completion_date":"2027-09-03","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07432958","publication_url":"https://clinicaltrials.gov/study/NCT07432958","title":"Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations","has_exemption":false,"start_date":"2026-02-25","completion_date":"2027-09-03","has_results":false,"results_due":false,"sponsor_name":"Appello Pharmaceuticals, Inc.","sponsor_slug":"appello-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07415954","publication_url":"https://clinicaltrials.gov/study/NCT07415954","title":"Efficacy and Safety of Once-weekly Subcutaneous NNC0662-0419 in Participants With Type 2 Diabetes - a Dose-finding Study","has_exemption":false,"start_date":"2026-04-17","completion_date":"2027-09-03","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04082520","publication_url":"https://clinicaltrials.gov/study/NCT04082520","title":"A Prospective, Phase II Study of Lutetium Lu 177 Dotatate (LUTATHERA®) in Patients With Inoperable, Progressive Meningioma After External Beam Radiation Therapy","has_exemption":false,"start_date":"2020-04-14","completion_date":"2027-09-04","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06617481","publication_url":"https://clinicaltrials.gov/study/NCT06617481","title":"RhPSMA-7.3(18F)-PET Scan to Detect Prostate Cancer in Patients with Early PSA Recurrence","has_exemption":false,"start_date":"2024-09-20","completion_date":"2027-09-05","has_results":false,"results_due":false,"sponsor_name":"AdventHealth","sponsor_slug":"adventhealth","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212049","publication_url":"https://clinicaltrials.gov/study/NCT07212049","title":"Using Ultrasound as an Alternative to Radiography in Measuring Magnetically Controlled Growing Rods (MCGR) in Tibia and Femur Lengthening Patients","has_exemption":false,"start_date":"2025-09-05","completion_date":"2027-09-05","has_results":false,"results_due":false,"sponsor_name":"Nemours Children's Clinic","sponsor_slug":"nemours-childrens-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05534438","publication_url":"https://clinicaltrials.gov/study/NCT05534438","title":"Stereotactic Body Radiation Therapy (SBRT) to Extend the Benefit of Systemic Therapy in Patients With Solitary Disease Progression","has_exemption":false,"start_date":"2022-09-06","completion_date":"2027-09-06","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05980949","publication_url":"https://clinicaltrials.gov/study/NCT05980949","title":"Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)","has_exemption":false,"start_date":"2023-07-11","completion_date":"2027-09-07","has_results":false,"results_due":false,"sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","sponsor_slug":"karuna-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04635189","publication_url":"https://clinicaltrials.gov/study/NCT04635189","title":"A Phase II Study of Steroid Sparing Treatment With Daratumumab and Lenalidomide in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma","has_exemption":false,"start_date":"2021-07-27","completion_date":"2027-09-08","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07178080","publication_url":"https://clinicaltrials.gov/study/NCT07178080","title":"Comparative Analysis of PIUR Imaging Technology for Volume Reduction Rate Measurement in Thyroid Nodule Ablations","has_exemption":false,"start_date":"2025-09-08","completion_date":"2027-09-08","has_results":false,"results_due":false,"sponsor_name":"Sarasota Memorial Health Care System","sponsor_slug":"sarasota-memorial-health-care-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06561360","publication_url":"https://clinicaltrials.gov/study/NCT06561360","title":"A Randomized, Multi-Center, Phase II Study of Vemurafenib Plus Obinutuzumab vs. Cladribine Plus Rituximab in Patients With Previously Untreated Hairy Cell Leukemia (HCL)","has_exemption":false,"start_date":"2024-09-09","completion_date":"2027-09-09","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null}]}